Depression and wish to die in a multicenter cohort of ALS patients

References

• Stutzki R, Weber M, Reiter-Theil S, Simmen U, Borasio G, Jox R. Attitudes toward hastened death in ALS: a prospective study of patients and family caregivers. Amyotroph Lateral Scler Frontotemporal Dementia. 2013;15:68–76.
   PubMed Web of Science ®Google Scholar
• Maessen M, Veldink J, Onwuteaka-Philipsen B, Hendricks H, Schelhaas H, Grupstra H, et al. Euthanasia and physician-assisted suicide in amyotrophic lateral sclerosis: a prospective study. J Neurol. 2014;261:1894–901.
   PubMed Web of Science ®Google Scholar
• Maessen M, Veldink J, Onwuteaka-Philipsen B, de Vries J, Wokke J, van der Wal G, et al. Trends and determinants of end-of-life practices in ALS in the Netherlands. Neurology. 2009;73:954–61.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Wagner G, del Bene M. Resilience and distress among amyotrophic lateral sclerosis patients and caregivers. Psychosom Med. 2000;62:271–9.
   PubMed Web of Science ®Google Scholar
• McLeod J, Clarke D. A review of psychosocial aspects of motor neuron disease. J Neurological Sciences. 2007; 258:4–10.
   PubMed Web of Science ®Google Scholar
• Huey E, Koppel J, Armstrong N, Grafman J, Floeter K. A pilot study of the prevalence of psychiatric disorders in PLS and ALS. Amyotroph Lateral Scler. 2010;11: 293–7.
   PubMed Web of Science ®Google Scholar
• Kurt A, Nijboer F, Matuz T, Kubler A. Depression and anxiety in individuals with amyotrophic lateral sclerosis: epidemiology and management. CNS Drugs. 2007;21: 279–91.
   PubMed Web of Science ®Google Scholar
• Averill A, Kasarskis E, Segerstrom S. Psychological health in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007;8:243–54.
   PubMed Web of Science ®Google Scholar
• Lou J, Reeves A, Benice T, Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology. 2003;60:122–3.
   PubMed Web of Science ®Google Scholar
• Gibbons C, Thornton E, Ealing J, Shaw P, Talbot K, Tennart A, et al. The impact of fatigue and psychosocial variables on quality of life for patients with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Dementia. 2013;14:537–45.
   PubMed Web of Science ®Google Scholar
• Ganzini L, Johnston W, McFarland B, Tolle S, Lee M. Attitudes of patients with amyotrophic lateral sclerosis and their caregivers toward assisted suicide. N Engl J Med. 1998; 339:967–73.
   PubMed Web of Science ®Google Scholar
• Rabkin JG, Albert S, del Bene M, O’Sullivan I, Tider T, Rowland L. Prevalence of depressive disorders and change over time in late-stage ALS. Neurology. 2005;65:62–7.
   PubMed Web of Science ®Google Scholar
• Hammer EM, Hacker S, Hautzinger M, Meyer T, Kubler A. Validity of the ALS-Depression Inventory (ADI-12) – a new screening instrument for depressive disorders in patients with amyotrophic lateral sclerosis. J Affec Dis. 2008;109:213–9.
   PubMed Web of Science ®Google Scholar
• McElhiney M, Rabkin J, Gordon P, Goetz R, Mitsumoto H. Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry. 2009; 80:1146–9.
   PubMed Web of Science ®Google Scholar
• Albert SM, Rabkin JG, del Bene M, Tider T, O’Sullivan I, Rowland L. Wish to die in end-stage amyotrophic lateral sclerosis. Neurology. 2005;645:68–74.
   Google Scholar
• Olney R, Lomen-Hoerth C. Exit strategies in ALS: an influence of depression or despair? Neurology. 2005;65:9–10.
   PubMed Web of Science ®Google Scholar
• World Federation NRGoAS. Revised El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. 2000; www.wfnals.org
   Google Scholar
• Mitsumoto H, Factor-Litvak P, Andrews H, Goetz R, Andrews L, Rabkin J.ALS Multi-Center Study of Oxidative Stress (COSMOS): Study methodology, recruitment, and baseline demographic and disease characteristics. Amyotroph Lateral Scler Frontotemporal Degener. 2014;15: 192–203.
   PubMed Web of Science ®Google Scholar
• Spitzer R, Kroenke K, Williams J. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care Study. JAMA. 1999;282:1737–44.
   PubMed Web of Science ®Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders, 4th edn. DSM-IV. American Psychiatric Association, Washington D.C., 1994.
   Google Scholar
• Diagnostic and Statistical Manual of Mental Disorders, 5th edn. DSM-V. American Psychiatric Publishing, Washington D.C., 2013.
   Google Scholar
• Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: The Hopelessness Scale. J Consult Clin Psychol. 1974;42:861–5.
   PubMed Web of Science ®Google Scholar
• Watson D, Clark L, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS Scales. J Pers & Soc Psychology. 1988;54:1063–70.
   PubMed Web of Science ®Google Scholar
• Linn MW. A Global Assessment of Recent Stress Scale (GARS). Int J Psychiatry in Medicine. 1986;15:47–59.
   Web of Science ®Google Scholar
• Endicott J, Nee J, Harrison W, Blumenthal R. Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q). In: Rush AJ, First M, Blacker D, editors. Handbook of Psychiatric Measures, 2nd edn. Washington DC: American Psychiatric Publishing; 2008. pp 133–4.
   Google Scholar
• Manne S, Pape S, Taylor K, Dougherty J. Spouse support, coping and mood among individuals with cancer. Ann Behav Med. 1999;21:111–21.
   PubMed Web of Science ®Google Scholar
• Mojtabai R. Diagnosing depression in older adults in primary care. N Engl J Med. 2014; 370:1180–2.
   PubMed Web of Science ®Google Scholar
• Siegert RJ, Abernethy D. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76:469–75.
   PubMed Web of Science ®Google Scholar
• Anderson R, Freedland K. The prevalence of comorbid depression in adults with diabetes. Diabetes Care. 2001;24: 1069–78.
   PubMed Web of Science ®Google Scholar
• Lesperance F, Frasure-Smith N, Koszycki D, Laliberte M, van Zyl L, Baker B, et al.Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease. JAMA. 2007;297:367–9.
   PubMed Web of Science ®Google Scholar
• Lule D, Zickler C, Hacker S, Bruno M, Demertzi A, Pellas F, et al. Life can be worth living in locked-in syndrome. Progress in Brain Research. 2009;177:339–51.
   PubMed Web of Science ®Google Scholar
• Chio A, Logroscino G, Traynor BJ, Collins J, Simone J, Goldstein L, et al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118–30.
   PubMed Web of Science ®Google Scholar